A recent study by Roland Berger predicts that the global robotic surgery market will experience significant growth, averaging 13.7% annually, and reach a value of $21.5 billion by 2030. The Asia Pacific (APAC) region is expected to witness the fastest growth, with its market share increasing from 17% in 2022 to 24% by 2030, driven primarily by China, Japan, and South Korea.
While North America will remain the largest market, its share of global revenues is anticipated to decrease from 60% in 2022 to 50% in 2030.
Robotic-assisted surgeries are predicted to be most commonly used in general surgery (48%), urology (16%), gynecology (13%), and orthopedics (12%).
Despite this significant growth potential, the industry faces challenges such as high investment and operating costs compared to traditional surgical methods, slower-than-expected adoption, and limitations in certain medical areas. These challenges are being addressed with competitive pricing and ongoing innovation in the sector.
The study highlights the expanding opportunities in the robotic surgery market and its potential to revolutionize various medical fields.
